Press Releases
Looking for more press releases? Explore our full press release archive by date to access past announcements, news updates, and media releases published on US Healthcare Journal.
Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference
Business Wire
·
June 2, 2025
Pfizer Inc. (NYSE: PFE) invites investors and the general public to listen to a webcast of a discussion with Albert Bourla, Chairman and Chief Executive Officer, at the Goldman Sachs 46th Annual Global Healthcare Conference on Monday, June 9, 2025...
Nuclear Imaging Equipment Market to Reach $5.46B by 2031 Amid Rising Chronic Disease & Tech | DataM Intelligence
EIN Presswire
·
June 2, 2025
Nuclear Imaging Equipment Market is set to grow to $5.46B by 2031, driven by tech advances, rising chronic diseases, and expanding global healthcare needs. AUSTIN, TX, UNITED STATES, June 2, 2025 /EINPresswire.com/ -- The Nuclear Imaging...
ELV STOCK: Suffer Losses on Elevance Health, Inc.? BFA Law Notifies Investors of Imminent July 11 Securities Class Action Deadline (NYSE:ELV)
GlobeNewswire, Inc.
·
June 2, 2025
NEW YORK, June 02, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Elevance Health, Inc. (NYSE: ELV) and certain of the Company’s senior executives for potential...
Cloudastructure Inc. to Present at Maxim Group’s “2025 Virtual Tech Conference: Discover the Innovations Reshaping Tomorrow,” June 3rd –June 5th
GlobeNewswire, Inc.
·
June 2, 2025
PALO ALTO, CA, June 02, 2025 (GLOBE NEWSWIRE) -- Cloudastructure, Inc. (Nasdaq: CSAI) (“we,” “us,” “our,” “Cloudastructure” or the “Company”) a recognized leader in AI surveillance and remote guarding solutions today announced that James...
ADDING MULTIMEDIA Clairity Becomes the First FDA-Authorized AI Platform for Breast Cancer Prediction – Historic Milestone for Women’s Health
Business Wire
·
June 2, 2025
Clairity, Inc., a digital health innovator advancing AI-driven healthcare solutions, has received U.S. Food and Drug Administration (FDA) De Novo authorization for CLAIRITY BREAST, a novel, image-based prognostic platform designed to predict...
Theoria Medical Expands Industry-Leading Senior Leadership Team with Key Hires
Business Wire
·
June 2, 2025
Theoria Medical™ (“Theoria” or the “Company”), a leading physician-led organization transforming the delivery of care across post-acute and senior living settings, today announced the following appointments to its senior leadership team in support...
Diversified Healthcare Trust Closes $94 Million of Mortgage Financings Secured by Six SHOP Communities
Business Wire
·
June 2, 2025
Diversified Healthcare Trust (Nasdaq: DHC) today announced that it has closed two fixed rate mortgage financings totaling $94.3 million, secured by six senior housing communities managed by Five Star Senior Living, the operating division of...
Catalyst Pharmaceuticals Announces Appointment of William T. Andrews, MD, FACP as Chief Medical Officer
GlobeNewswire, Inc.
·
June 2, 2025
CORAL GABLES, Fla., June 02, 2025 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX) today announced the appointment of William (Will) T. Andrews, MD, FACP as Chief Medical Officer. Dr. Andrews will report...
TG Therapeutics to Participate in the Jefferies Global Healthcare Conference
GlobeNewswire, Inc.
·
June 2, 2025
NEW YORK, June 02, 2025 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX) today announced that Michael S. Weiss, the Company’s Chairman and Chief Executive Officer, will participate in the Jefferies Global Healthcare Conference, being held...
Confluent Health Releases Groundbreaking Documentary to Tackle America’s Chronic Pain Crisis
GlobeNewswire, Inc.
·
June 2, 2025
LOUISVILLE, Ky., June 02, 2025 (GLOBE NEWSWIRE) -- What if everything we thought we knew about pain was wrong? Today, more than 1 in 5 Americans live with chronic pain, and too often, their pain is met with silence, surgery, or a prescription pad....
Essy Mozaffari, PharmD, MPH, MBA Joins eMAX Health as Head of Real-World Evidence
GlobeNewswire, Inc.
·
June 2, 2025
DELRAY BEACH, Fla., June 02, 2025 (GLOBE NEWSWIRE) -- eMAX Health is pleased to announce the appointment of Essy Mozaffari, PharmD, MPH, MBA as Senior Vice President and Head of Real-World Evidence. Dr. Mozaffari brings over 25 years of leadership...
ENHERTU® Plus Pertuzumab Reduced the Risk of Disease Progression or Death by 44% Versus THP as First-Line Therapy in Patients with HER2 Positive Metastatic Breast Cancer in DESTINY-Breast09 Phase 3 Trial
Business Wire
·
June 2, 2025
Positive results from the DESTINY-Breast09 phase 3 trial showed ENHERTU® (trastuzumab deruxtecan) plus pertuzumab demonstrated a highly statistically significant and clinically meaningful improvement in progression-free survival (PFS) compared to...
PDS Biotech Unveils Updated Positive Data From VERSATILE-002 Trial and Additional Trials Evaluating Versamune® HPV to Treat Head and Neck Cancers at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting
GlobeNewswire, Inc.
·
June 2, 2025
Median overall survival data in first-line recurrent/metastatic (1L r/m) HNSCC remains durable at 30.0 months with additional follow-up of ~4.5 months beyond the initial abstract HPV16-positive is the most rapidly increasing HNSCC in the US...
CareCloud to Present on AI Innovation at Maxim Group’s 2025 Virtual Tech Conference on June 3, 2025
GlobeNewswire, Inc.
·
June 2, 2025
Somerset, N.J., June 02, 2025 (GLOBE NEWSWIRE) -- CareCloud, Inc. (Nasdaq: CCLD, CCLDO) (“CareCloud” or the “Company”), a leader in AI-driven healthcare technology solutions for medical practices and health systems nationwide, announced today that...
Campbell's Reports Third Quarter Fiscal 2025 Results
Business Wire
·
June 2, 2025
The Campbell's Company (NASDAQ:CPB) today reported results for its third quarter fiscal 2025 ended April 27, 2025. Unless otherwise stated, all comparisons are to the same period of fiscal 2024. The Sovos Brands, Inc. (Sovos Brands) acquisition...
Global Tortilla Market Set for Robust Growth, Driven by Health Trends and Expanding Consumer Base | FMI
EIN Presswire
·
June 2, 2025
The global tortilla market is experiencing steady growth driven by increasing consumer demand for convenient and authentic ethnic foods. NEWARK, DE, UNITED STATES, June 2, 2025 /EINPresswire.com/ -- The global tortilla market is poised for...
ASU, Labcorp, and InStride announce first-of-its-kind diagnostics industry partnership that tackles critical healthcare workforce shortage
GlobeNewswire, Inc.
·
June 2, 2025
LOS ANGELES, June 02, 2025 (GLOBE NEWSWIRE) -- InStride, a leading provider of strategic education and skilling solutions, has facilitated a unique partnership between Arizona State University’s College of Health Solutions and Labcorp, a global...
uniQure Provides Regulatory Update on AMT-130 for Huntington’s Disease
GlobeNewswire, Inc.
·
June 2, 2025
~ Alignment with FDA continues to support Accelerated Approval pathway ~ ~ BLA submission planned for first quarter of 2026 ~ ~ Conference call today at 8:30 a.m. ET ~ LEXINGTON, Mass. and AMSTERDAM, June 02, 2025 (GLOBE NEWSWIRE) -- uniQure N.V....
Sanofi Exercises License Extension Option to Nurix’s STAT6 Program
GlobeNewswire, Inc.
·
June 2, 2025
STAT6 is a key transcription factor within the IL4/IL13 signaling pathways which act as drivers of inflammation in allergic conditions Nurix to receive a $15 million license extension fee from Sanofi under its 2019 collaboration agreement,...
Recludix Pharma Announces Development Candidate Nomination of First-in-Class Oral STAT6 Inhibitor for Inflammatory Diseases and Achievement of Significant Milestone Under Collaboration with Sanofi
GlobeNewswire, Inc.
·
June 2, 2025
--Completion of GLP toxicology studies associated with a $50 million payment to Recludix under the collaboration with Sanofi -- REX-8756 is a potent and selective oral STAT6 inhibitor that demonstrates complete pathway inhibition and is well...